10-Q · May 15, 2026
SINTX Technologies reported a modest revenue increase of 3% in Q1 2026 compared to Q1 2025, with total revenue at $300,000. The company's gross profit margins improved slightly, and while losses increased, management…
Earnings analysis · 10-Q
SINT earnings analysis
Filed August 11, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, MD&A, or segment disclosures, so revenue, margins, EPS, cash flow, working-capital trends, and year-over-year…
Read full summary
The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, MD&A, or segment disclosures, so revenue, margins, EPS, cash flow, working-capital trends, and year-over-year comparisons cannot be assessed from the provided filing text. Controls were effective as of June 30, 2026, and the company reported no material pending legal proceedings. The principal newly disclosed item is a CFO change-in-control agreement that could create cash severance, healthcare, and equity-vesting obligations, including a 2-times lump-sum formula and up to 36 months of medical-plan payments.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Disclosure controls deemed effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, the end of the reporting period.
-
No material pending litigation
The company reported no material pending legal proceeding as of the filing date.
-
Repurchase authorization remains available
The share repurchase authorization permits up to $500,000 of purchases; $366,935 remained available as of June 30, 2026, although no shares were repurchased during the quarter.
What to watch
-
Potential change-in-control costs
The August 7, 2026 change-in-control agreement provides the CFO with a lump-sum payment equal to 2 times the sum of annual base salary and a specified annual bonus amount following certain qualifying terminations, plus other benefits.
-
Severance and equity acceleration
The CFO agreement may require monthly medical-plan continuation payments for up to 36 months following a qualifying termination and may accelerate vesting of outstanding time-based equity awards.
-
No new formal risk-factor changes
The filing states that there have been no material changes from the risk factors in the 2025 Form 10-K filed March 20, 2026; therefore, no new formal risk-factor changes were identified in the supplied report.
Management's outlook
No quantitative revenue or EPS outlook was disclosed in the supplied 10-Q extract. The filing does not provide an earnings outlook or update to prior guidance.
Earlier filings 4
10-K · March 20, 2026
SINTX Technologies, Inc. reported a net loss of $10.4 million for the year ended December 31, 2025, with total revenue declining by 65% to $1.018 million due to strategic shifts away from low-margin OEM contracts. The…
10-Q · November 12, 2025
SINTX Technologies reported significantly lower Q3 2025 results, with revenue of $208,000, down 74% year-over-year, and a net loss of $3.54 million, compared to a loss of $6.24 million in 2024. The decline was…
10-Q · August 14, 2025
SINT reported a significant decline in revenue in Q2 2025, totaling $151,000, which fell short of the $400,000 consensus estimate. The company's gross margin was down to 37.8%, and it reported a diluted EPS of -0.91,…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.